Myelopathy following radiotherapy of nasopharyngeal carcinoma.
D000328:Adult; D000367:Age Factors; D001927:Brain Diseases / Q000209:etiology*; D001933:Brain Stem / Q000473:pathology / Q000528:radiation effects*; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D003036:Cobalt Isotopes / Q000008:administration & dosage; D003711:Demyelinating Diseases / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D011149:Pons / Q000473:pathology; D011379:Prognosis; D011867:Radioisotope Teletherapy / Q000009:adverse effects*; D011878:Radiotherapy / Q000009:adverse effects*; D012737:Sex Factors; D013116:Spinal Cord / Q000473:pathology; D013118:Spinal Cord Diseases / Q000209:etiology*
D003036:Cobalt Isotopes